Financing, Equity Capital Markets

Menlo Therapeutics Inc.

06/20
|
$50.0 Million
Piper Sandler served as bookrunner for Menlo Therapeutics Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma